TherapeuticsMD (TXMD) Return on Invested Capital (2022)

TherapeuticsMD's (TXMD) quarterly Return on Invested Capital came in at 0.0% in Q3 2022, up 41.82% on a QoQ basis from 0.0% in Q2 2022.

TherapeuticsMD (TXMD) Return on Invested Capital (2022) Analysis & Trends

TherapeuticsMD (TXMD) has 1 years of Return on Invested Capital data on file, last reported at 0.0% in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	0.00%
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	0.00%
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	0.03%
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	TherapeuticsMD	23.78 Mn	14.60 Mn	-	-

Download Data

Date	Value
Sep 30, 2022	0.00%
Jun 30, 2022	0.00%